ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species

Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*广州医学院; 广州中医药大学; 1; 5
Clinical and Translational Medicine2021-5DOI: 10.1002/ctm2.392
31被引19阅读
引用收藏
分享

摘要

Background and purpose Osteoporosis is characterized by excessive bone resorption due to enhanced osteoclast activation. Stimulation of nuclear factor of activated T cells 1 (NFATc1) and accumulation of reactive oxygen species (ROS) are important mechanisms underlying osteoclastogenesis. Robinin (Rob) is a flavonoid glycoside that has shown anti-inflammatory and antioxidative effects in previous studies, but little is known about its effects on bone homeostasis. The purpose of our research was to investigate whether Rob could prevent bone resorption in ovariectomized (OVX) mice by suppressing osteoclast production through its underlying mechanisms. @@@ Methods The docking pose of Rob and RANKL was identified by protein-ligand molecular docking. Rob was added to bone marrow macrophages (BMMs) stimulated by nuclear factor-kappa B (NF-kappa B) ligand (RANKL). The effects of Rob on osteoclastic activity were evaluated by positive tartrate resistant acid phosphatase (TRAcP) staining kit and hydroxyapatite resorption assay. RANKL-induced ROS generation in osteoclasts was detected by H(2)DCFDA and MitoSox Red staining. The classic molecular cascades triggered by RANKL, such as NF-kappa B, ROS, calcium oscillations, and NFATc1-mediated signaling pathways, were investigated using Fluo4 staining, western blot, and quantitative real-time polymerase chain reaction. In addition, an OVX mouse model mimicking estrogen-deficient osteoporosis was created to evaluate the therapeutic effects of Rob in vivo. @@@ Results Computational docking results showed that Rob could bind specifically to RANKL's predicted binding sites. In vitro, Rob inhibited RANKL-mediated osteoclastogenesis dose-dependently without obvious cytotoxicity at low concentrations. We also found that Rob attenuated RANKL-induced mitochondrial ROS production or enhanced activities of ROS-scavenging enzymes, and ultimately reduced intracellular ROS levels. Rob abrogated the RANKL-induced mitogen-activated protein kinase (MAPK) and NF-kappa B signaling pathways, and subsequently blocked NFATc1 signaling and TRAcP expression. In addition, Rob inhibited osteoclast proliferation by downregulating the expression of osteoclast target genes (Acp5, Cathepsin K, Atp6v0d2, Nfact1, c-Fos, and Mmp9) and reducing Ca2+ oscillations. Our in vivo results showed that Rob reduced bone resorption in OVX animal model by repressing osteoclast activity and function. @@@ Conclusions Rob inhibits the activation of osteoclasts by targeting RANKL and is therefore a potential osteoporosis drug.

学科与关键词

关键词
NFAcT1osteoclastosteoporosisRANKLRobininROS
相关
加载中…
  • Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways
    Wang, Gang; Chen, Kai; Ma, Chao; Wang, Chao; Chen, Delong; He, Jianbo; Liu, Yuhao; Jiang, Tao; Yuan, Jinbo; Chen, Leilei; He, Wei*; Xu, Jiake*Journal of Cellular Physiology, 2022, 237(3): 1790-1803.被引 8
  • A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
    Wong, Puiian; Lv, Zheng; Li, Jinglan; Wei, Qiushi; Xu, LiangLiang*; Fang, Bin*; Luo, Yiwen*; He, Mincong*Oxidative Medicine and Cellular Longevity, 2022, 2022: 5982014.被引 6
  • Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone loss
    Cao, Zhen; Niu, Xuben; Wang, Maihuan; Yu, Siwang; Wang, Mingkun; Mu, Silong; Liu, Chuan*; Wang, Yaxi*Biomedicine and Pharmacotherapy, 2023, 167: 115454.
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical and Translational Medicine
发表日期
2021-05
卷期
第 11 卷, 第 5 期
页码
e392
DOI
10.1002/ctm2.392
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2017A030313698, S2013040014927]; National Natural Science Foundation of China [81302994, 81573996, 81873327, 81904226]; Science andTechnology Planning Project of Guangdong Province [2012A032500005, 2014A020221041, 2016A020226028]

作者

  • H

    Hong, Guoju (第一作者)

    guangzhou univ chinese med

  • C

    Chen, Zhenqiu

    1 · guangzhou univ chinese med

查看全部 12 位作者收起作者
  • H

    Han, Xiaorui

  • Z

    Zhou, Lin

    5 · guangzhou med univ

  • P

    Pang, Fengxiang

    1 · guangzhou univ chinese med

  • W

    Wu, Rishana

    1 · guangzhou univ chinese med

  • S

    Shen, Yingshan

    1 · guangzhou univ chinese med

  • H

    He, Xiaoming

    1 · guangzhou univ chinese med

  • H

    Hong, Zhinan

    guangzhou univ chinese med

  • L

    Li, Ziqi

    guangzhou univ chinese med

  • H

    He, Wei

    guangzhou univ chinese med

  • W

    Wei, Qiushi (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417